The Pre-Rulemaking Measure Review Preliminary Assessments (PAs) offer a standardized baseline evaluation of measures on the Measures Under Consideration (MUC) List to aid committee discussions for CMS program suitability. PRMR committee members examine and discuss measure suitability before the PRMR Recommendation Group Meetings in January 2025.
Public feedback is encouraged. Please visit the MUC List public comment page to submit comments by December 30, 2024.
Battelle conducted PAs to evaluate the following objectives:
- Assess information completed provided by the CMS MUC Entry/Review Information Tool (MERIT) submissions
- Evaluate measure evidence against the Meaningfulness, Appropriateness to Scale, and Time-to-Value Realization
For more information, please view the PRMR Guidebook.
Public access to supporting materials is available on the 2024 MUC List Supporting Materials page on the Measures Management System Hub.
Find a detailed overview of PA development and educational resources in the 2024 PRMR Overview.
Measure Under Consideration 2024 Preliminary Assessments
Clinician Committee:
- MUC2024-025: Diagnostic Delay of Venous Thromboembolism (DOVE) in Primary Care
- MUC2024-026: Person-Centered Outcome Measures: Goal-Identification, Follow-Up, and Goal Achievement
- MUC2024-028: Screening for Abnormal Glucose Metabolism in Patients at Risk of Developing Diabetes
- MUC2024-031: Hepatitis C Virus (HCV): Sustained Virological Response (SVR)
- MUC2024-049: Breast Cancer Screening
- MUC2024-051: Prevalent Standardized Waitlist Ratio (PSWR)
- MUC2024-052: Social Need Screening and Intervention
- MUC2024-072: Addressing Social Needs Assessment & Intervention
- MUC2024-079: Assessment of Autonomic Dysfunction and Follow-Up
- MUC2024-080: Patient Reported Falls and Plan of Care
- MUC2024-081: Adult Immunization Status (AIS-E)
- MUC2024-082: Cancer Screening and Counseling Patient-Reported Outcome-Based Measure (PRO-PM)
- MUC2024-084: Quality of life outcome for patients with neurologic conditions
- MUC2024-088: Depression Screening and Follow-Up for Adolescents and Adults (DSF)
- MUC2024-100: Non-Pressure Ulcers
- MUC2024-101: Parkinson’s Syndromes, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS)
Hospital Committee:
- MUC2024-027: Patient Safety Structural Measure
- MUC2024-030: Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Acute Myocardial Infarction (AMI) Hospitalization
- MUC2024-032: Hospital 30-day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Heart Failure (HF) Hospitalization
- MUC2024-034: Influenza Vaccination Coverage Among Healthcare Personnel
- MUC2024-040: Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Chronic Obstructive Pulmonary Disease (COPD) Hospitalization
- MUC2024-041: Hospital-Level, 30-Day, Risk-Standardized Readmission Rate (RSRR) Following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA)
- MUC2024-042: Hospital-Level, Risk-Standardized Complication Rate (RSCR) Following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA)
- MUC2024-043: Hospital 30-Day, All-Cause, Risk-Standardized Mortality Rate (RSMR) Following Acute Ischemic Stroke Hospitalization with Claims-Based Risk Adjustment for Stroke Severity
- MUC2024-045: Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Pneumonia Hospitalization
- MUC2024-046: Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Coronary Artery Bypass Graft (CABG) Surgery
- MUC2024-060: In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) Survey - Quality of Dialysis Center Care and Operations (QDCCO)
- MUC2024-067: Proportion of Patients Who Died from Cancer Admitted to the ICU in the Last 30 Days of Life
- MUC2024-068: Proportion of Patients Who Died From Cancer Receiving Chemotherapy in The Last 14 Days Of Life
- MUC2024-069: Addressing Social Needs Assessment & Intervention
- MUC2024-073: Patient Understanding of Key Information Related to Recovery After a Facility-Based Outpatient Procedure or Surgery, Patient Reported Outcome-Based Performance Measure (Information Transfer PRO-PM)
- MUC2024-074: Median Time to Pain Medication for Patients with a Diagnosis of Sickle Cell Disease (SCD) with Vaso-Occlusive Episode (VOE)
- MUC2024-075: Equity of Emergency Care Capacity and Quality (ECCQ
- MUC2024-078: Proportion of patients who died from cancer admitted to hospice for less than 3 days
- MUC2024-085: Hospital Harm – Anticoagulant-Related Major Bleeding
- MUC2024-095: Equity of Emergency Care Capacity and Quality (ECCQ)
Post-Acute Care/Long-Term Care Committee:
- MUC2024-054a: CAHPS® Home Health Care Survey Care of Patients
- MUC2024-054b: CAHPS® Home Health Care Survey Communications Between Providers and Patients
- MUC2024-054c: CAHPS® Home Health Care Survey Talk About Home Safety
- MUC2024-054d: CAHPS® Home Health Care Survey Review Medicines
- MUC2024-054e: CAHPS® Home Health Care Survey Talk About Medicine Side Effects